Molecular Medicine Tri-Conference
The annual Molecular Medicine Tri-Conference has become one of the world’s leading international events in the field of drug discovery, development and diagnostics. The Tri-Conference unites an ecosystem of 3,700 innovative thinkers and thought leaders throughout biotech, pharma and academia from around the world.
XiFin was proud to support the Molecular Medicine Tri-Conference this year as a corporate sponsor that included speaking at the following sessions.
Sessions:
Closing the Gap: Commercialization and Coverage for Novel Diagnostics
Kyle Fetter, Executive Vice President & General Manager of Diagnostic Services, XiFin, Inc.
Molecular Diagnostics track
Monday, February 12, 2018
4:25 PM – 4:40 PM PT
Integrated Workflow: A Seamless Experience for Digital Case Management
Digital Pathology track
Tuesday, February 13, 2018
11:30 AM – 12:00 PM PT
Panel Discussion: AI vs. Medical Doctor
Patricia Goede, Vice President, Clinical Informatics, XiFin, Inc.
Digital Pathology track
Wednesday, February 14, 2018
2:30 PM – 3:30 PM PT
Moderator:
Keith J. Kaplan, M.D., Pathologist, CMO, Corista LLC; Publisher, Tissuepathology.Com
Additional Speakers:
Dan Hosseinzadeh, CEO, Pathcore; Co-Chair, DICOM Pathology Working Group
Liron Pantanowitz, M.D., Professor, Pathology & Biomedical Informatics, University of Pittsburgh Medical Center
Cambridge Healthtech Institute (CHI), a division of Cambridge Innovation Institute, is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Cambridge Marketing Consultants, Barnett International, Cambridge Meeting Planners and Healthtech Publishing, which includes Bio-IT World, Clinical Informatics News and Diagnostics World.